Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Successful, multiresistant bacterial clones.

Neil Woodford1

  • 1Antibiotic Resistance Monitoring and Reference Laboratory, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK. neil.woodford@hpa.org.uk

The Journal of Antimicrobial Chemotherapy
|December 14, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic and molecular characterisation of a KPC-producing Klebsiella pneumoniae clinical isolate resistant to meropenem-vaborbactam, imipenem-relebactam, and ceftazidime-avibactam.

BMC genomic data·2026
Same author

Correction: Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.

BMC infectious diseases·2025
Same author

Frequencies and mechanisms of mutational resistance to ceftibuten/avibactam in Enterobacterales.

The Journal of antimicrobial chemotherapy·2024
Same author

Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015-24: an observational analysis.

The Journal of antimicrobial chemotherapy·2024
Same author

Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance.

International journal of antimicrobial agents·2024
Same author

Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coli.

International journal of antimicrobial agents·2023
Same journal

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same journal

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same journal

Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

The Journal of antimicrobial chemotherapy·2026
Same journal

Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

The Journal of antimicrobial chemotherapy·2026
See all related articles

Multilocus sequence typing reveals bacterial population structures, identifying international clones causing infections. Many of these clones exhibit multidrug resistance, impacting healthcare.

Area of Science:

  • Microbiology
  • Population Genetics
  • Infectious Diseases

Background:

  • Multilocus sequence typing (MLST) provides deep insights into bacterial population biology.
  • This technique is crucial for studying bacteria responsible for healthcare-associated and community-acquired infections.

Discussion:

  • The study highlights the emergence of internationally prevalent bacterial clones.
  • These clones frequently display resistance to multiple antibiotics, posing significant challenges.

Key Insights:

  • MLST is instrumental in understanding the global spread of specific bacterial strains.
  • Identification of multidrug-resistant clones is critical for effective infection control.

Outlook:

  • Further research using MLST can guide strategies against antimicrobial resistance.

Related Experiment Videos

  • Understanding clone dynamics is essential for public health and clinical microbiology.